- Home
- GMGI vs CGEN Comparison
GMGI vs CGEN Comparison
Compare GMGI & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- CGEN
- Stock Information
- Founded
- GMGI 2008
- CGEN 1993
- Country
- GMGI United States
- CGEN Israel
- Employees
- GMGI N/A
- CGEN N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GMGI Technology
- CGEN Health Care
- Exchange
- GMGI Nasdaq
- CGEN Nasdaq
- Market Cap
- GMGI 142.5M
- CGEN 125.3M
- IPO Year
- GMGI N/A
- CGEN 2000
- Fundamental
- Price
- GMGI $1.03
- CGEN $1.75
- Analyst Decision
- GMGI Strong Buy
- CGEN
- Analyst Count
- GMGI 1
- CGEN 0
- Target Price
- GMGI $4.00
- CGEN N/A
- AVG Volume (30 Days)
- GMGI 242.1K
- CGEN 377.9K
- Earning Date
- GMGI 11-12-2025
- CGEN 11-11-2025
- Dividend Yield
- GMGI N/A
- CGEN N/A
- EPS Growth
- GMGI N/A
- CGEN N/A
- EPS
- GMGI N/A
- CGEN N/A
- Revenue
- GMGI $172,818,124.00
- CGEN $22,144,000.00
- Revenue This Year
- GMGI $25.43
- CGEN N/A
- Revenue Next Year
- GMGI $13.00
- CGEN $208.08
- P/E Ratio
- GMGI N/A
- CGEN N/A
- Revenue Growth
- GMGI 54.66
- CGEN N/A
- 52 Week Low
- GMGI $0.91
- CGEN $1.13
- 52 Week High
- GMGI $3.06
- CGEN $2.66
- Technical
- Relative Strength Index (RSI)
- GMGI 38.89
- CGEN 66.91
- Support Level
- GMGI $1.06
- CGEN $1.30
- Resistance Level
- GMGI $1.16
- CGEN $1.82
- Average True Range (ATR)
- GMGI 0.09
- CGEN 0.11
- MACD
- GMGI 0.02
- CGEN 0.05
- Stochastic Oscillator
- GMGI 24.97
- CGEN 85.32
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.